maltol has been researched along with 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Cheng, G; Ma, Y; Sheng, R; Xu, P; Zhang, M | 1 |
1 other study(ies) available for maltol and 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid
| Article | Year |
|---|---|
Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Benzothiazoles; Chelating Agents; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Pyrones; Resveratrol; Structure-Activity Relationship; Sulfonic Acids | 2018 |